chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen, red, itchy, and spreading/ progressing.; Swollen, red, itchy, and spreading/ progressing.; Rash on her left arm where the vaccination was given; Swollen, red, itchy, and spreading/ progressing.; Swollen, red, itchy, and spreading/ progressing.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (swollen, red, itchy, and spreading/ progressing.), VACCINATION SITE PRURITUS (Swollen, red, itchy, and spreading/ progressing.), VACCINATION SITE RASH (Rash on her left arm where the vaccination was given), VACCINATION SITE SWELLING (Swollen, red, itchy, and spreading/ progressing.) and VACCINATION SITE ERYTHEMA (Swollen, red, itchy, and spreading/ progressing.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced RASH (swollen, red, itchy, and spreading/ progressing.), VACCINATION SITE PRURITUS (Swollen, red, itchy, and spreading/ progressing.), VACCINATION SITE RASH (Rash on her left arm where the vaccination was given), VACCINATION SITE SWELLING (Swollen, red, itchy, and spreading/ progressing.) and VACCINATION SITE ERYTHEMA (Swollen, red, itchy, and spreading/ progressing.). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH (swollen, red, itchy, and spreading/ progressing.), VACCINATION SITE PRURITUS (Swollen, red, itchy, and spreading/ progressing.), VACCINATION SITE RASH (Rash on her left arm where the vaccination was given), VACCINATION SITE SWELLING (Swollen, red, itchy, and spreading/ progressing.) and VACCINATION SITE ERYTHEMA (Swollen, red, itchy, and spreading/ progressing.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided
Systemic: Cardiac Disorder (diagnosed by MD)-Severe, Systemic: Chest Tightness / Heaviness / Pain-Severe, Systemic: Tachycardia-Severe, Additional Details: Patient went to ER  after consistent chest pain/ tightness. Parent said that she was diagnosed with tachycardia.
Lost his appetite; Really flat out and it hit him hard; He might have had the flu and Covid at the same time; Still sound hoarse; Tested positive for Covid after receiving Moderna Covid/high fever for several days of 103 and whole body chills; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for Covid after receiving Moderna Covid/high fever for several daysof 103 and whole body chills), DECREASED APPETITE (Lost his appetite), FEELING ABNORMAL (Really flat out and it hit him hard), INFLUENZA (He might have had the flu and Covid at the same time) and DYSPHONIA (Still sound hoarse) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21BRAVO NDC, 045BRAVO21A NDC and 008BRAVO212A NDC) for COVID-19 prophylaxis.     Concurrent medical conditions included High cholesterol and Sleep apnea syndrome (Some kind of sleep apnea condition).   On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Apr-2022, the patient experienced COVID-19 (Tested positive for Covid after receiving Moderna Covid/high fever for several daysof 103 and whole body chills). On an unknown date, the patient experienced DECREASED APPETITE (Lost his appetite), FEELING ABNORMAL (Really flat out and it hit him hard), INFLUENZA (He might have had the flu and Covid at the same time) and DYSPHONIA (Still sound hoarse). At the time of the report, COVID-19 (Tested positive for Covid after receiving Moderna Covid/high fever for several daysof 103 and whole body chills), DECREASED APPETITE (Lost his appetite), FEELING ABNORMAL (Really flat out and it hit him hard), INFLUENZA (He might have had the flu and Covid at the same time) and DYSPHONIA (Still sound hoarse) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Apr-2022, SARS-CoV-2 test: (Positive) Positive. On 26-Apr-2022, SARS-CoV-2 test: (Positive) Positive for Covid. On an unknown date, Body temperature: high fever for several days of 103.         No concomitant medications were reported. Based on the symptoms, the nurse practitioner the patient might have had the flu and Covid at the same time. The patient was trying to get treatments and was very dissatisfied with his care. The patient did still sound hoarse and still not feeling 100 percent. He didn't have a fever anymore. The reporter was not sure if the patient had the flu or not. No treatment medications were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
This is a spontaneous report from a physician referring to a male in his thirties who received his 1st Lymerix and 2 weeks later, he found a deer tick on his chest. The tick was not engorged and came right off. On 8/18, the pt developed a rash on his chest which was splotchy with individual spots varying in size. It was not a bullseye rash. It was not itchy and there were no pustules. During the last week of 8/99, the pt received his 2nd dose of Lymerix. Subsequently, there was no change in the rash. The most recent information, received on 9/1/99, reports the condition of the pt is ongoing.
Patient said that she has been feeling weak and tired since injection. Her blood pressure has been running around 170/110. She is seeing her doctor on Sept 14, 2010. Nurse told her to take Lorazepam to lower blood pressure and they are continuing to monitor her.
Systemic: Fever-Medium, Systemic: Fever lasting 8 days-Medium
Approximately 2 weeks after receiving vaccine, patient was on a cruise with her husband when she developed an acute febrile illness with fevers to 105 degrees, profound weakness, confusion and generalized malaise. She was taken off the ship to a hospital in another country and after about 5 days was transferred back to her home country where she eventually was transferred to a rehab unit for recovery. She reports that she has never returned to normal - she has urinary incontinence and persitent profound fatigue and sleepiness. She describes a dramatic decrease in her ability to carry out her usual activities as well as, diffuse myalgias, arthralgias, and low back pain. She states that her thinking is not as clear or sharp, she has had frequent and severe headaches and occasional falls with left lower extremity weakness. She is seeing a neurologist who discovered that the patient also had a scratch from a sloth prior to the febrile illness and he referred her to an infectious disease specialist to look into this aspect. The ID physician ordered serolgies for St. Louis encephalitis, eastern equine encephalitis and HTLV-1 which were all negative. Mild mod problems with mentation, gait, voiding. Temporal relationship to yellow fever, causation unclear.
Rash around the injection site(at least two to three inches in diameter. First appeared about a week afterwards with some additional soreness. Rash was really red for two days and started getting better with Hydrocortisone cream.
got shots and still had a recurrence/ suspected vaccination failure; had a recurrence; internal deep nerve pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got shots and still had a recurrence/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: had a recurrence) and post herpetic neuralgia (Verbatim: internal deep nerve pain). The outcome of the vaccination failure, shingles and post herpetic neuralgia were not reported.   It was not reported if the reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.     It was not reported if the company considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.   Additional Information: GSK receipt date: 03-MAR-2023 This case was reported by a patient via interactive digital media. The patient got shots and still had a recurrence but the internal deep nerve pain not the rash. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Called to verify coming in for second dose on 4/21/21, family member confirmed death a few weeks ago (a few weeks after first covid dose). Cause of death unknown
Within 5-6 hours of injections. She developed high fever. Chills and hallucinations
Patient was given more vaccine than ordered by the pediatrician.  Ordered was only 2 shots. Patient was given 6.
PATIENT RECIEVED AN MMR VACCINE ON 11-15-02 AND THEN ON 11-28-02 WAS TREATED FOR MUMPS
Pain & swelling & heat to site Right deltoid. Awoke next morning with pain under arm & down arm to hand. Increased temp to 101.1. Saw MD that afternoon was started on Keflex. Temp reached 101.8 & were managed with alternating doses of motrin and tylenol on every 2 hr schedule.  She experienced light headedness & nausea feeling "out of sorts." Increased temps persisted for 3 days following shot. work loss was 3-1/2 days.
Information has been received from a health professional concerning a 16 year old female who on approximately 25-MAR-2008 was vaccinated with her first dose of Gardasil vaccine (lot# not reported). The patient fainted twice after receiving the vaccine. She was at the clinic when this occurred. She was taken to the ER where she was treated and released for vasovagal response to the immunization. The patient's mother reported that her daughter ate very little that day and was also emotionally upset that day. Her outcome was not reported. Additional information has been requested.
Case number PHEH2014US019549 is an initial spontaneous report received form a Healthcare Professional on 29 Sep 2014. This report refers to a 15 year old female patient. Her medical history and concomitant medication were not reported. She was vaccinated with a dose of FLUCELVAX (batch number: not reported) intramuscularly on 29 Sep 2014. No adverse event was reported following this administration error (inappropriate age at vaccine administration).
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history, concurrent condition and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored PEDVAXHIB (lot # M025194, expiration date 22-MAR-2019, dose and route not reported). It was reported that the vaccine was store at 47.69 F for 24 hours. The case was reported due to data logger issue. No adverse effects reported. Additional information has been requested.
Patient received booster dose of Pfizer Covid vaccine on 11/16. Same day of vaccine, she developed nausea, vomiting, body aches, hives, and fever. On 11/18, she developed intermittent headache and dizziness. She notified her PCP regarding symptoms and was informed that the symptoms were normal and most likely an immune response to the vaccine. She managed her symptoms with Tylenol, Motrin, and Zofran. She reports that her headache resolved on 11/22.
Following vax pt leg swelled; went home took nap-awoke fr nap had difficulty breathing-screamed for 1.5hrs taken to ER by rescue squad where continued to scream for a total of 3hrs, some vomiting;
over 42 days. 1st dose 05/25/21, 2nd dose 8/19/21
Narrative:  Patient with anxiety developed anxiety symptoms following administration of Pfizer Covid Vaccine. The symptoms gradually resolved over a short time and the patient was able to leave without issue.
Discharge Provider: DO Primary Care Provider: MD Admission Date: 9/10/2022 Discharge Date: Sep 12, 2022  PRESENTING PROBLEM: Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is an 81-year-old female with a past medical history of inclusion body myositis who presented with shortness of breath.  Patient had a fall in a week prior to admission.  She stated she tripped and fell and hit her face on the concrete.  She did not lose consciousness.  She was seen in the emergency department at that time and CT head and CT maxillofacial were negative.  She then developed a dry cough and became progressively more weak.  On 09/05/2022 she had a home COVID test that was positive.  Her shortness of breath progressively worsened, particularly with exertion and she had a dry cough.  In the emergency department, she was afebrile.  She was hypoxic at 83% with ambulation.  Labs were unremarkable.  UA was negative.  COVID screen was positive.  Chest x-ray showed no acute process.  She was admitted for COVID-19 infection and acute hypoxia with activity.   She was started on remdesivir and Decadron.  She did not require oxygen with activity on reeval.  Her fatigue and weakness improved that she could ambulate independently.  She was discharged home on 9/12/22.
42 y/o member with history of receiving smallpox vaccine as a re-vaccinee 3/6/03 along with "many other vaccines." He reports no ill effects at that time. In mid July he reports having GI symptoms (nausea), fatigue and SOB "about 2-3 weeks after receiving anthrax vaccine." On 8/14/03 he was admitted to hospital with increasing SOB, fatigue, abnormal liver function panel, and low levels of magnesium an dpotassium. A cardiac cath revealed minimal non-obstructed CAD, EF 10% and global HK. Since it has been determined that this member meets the criteria for Dilated Cardiomyopathy: 1) Cardiac muscle dysfunction exists, characterized by ventricular dilatation (e.g. left ventricular end-diatolic dimension >55 mm) and impaired contraction of one or both ventricles (e.g. left ventricular ejection fraction less than or equal to 0.45). 2) There is no evidence of DCM or congestive heart failure prior to vaccination, either by history (e.g. dyspnea on exertion, fatigue) or by cardiac evaluation, including chest radiography or echocardiography if available. 3) No other cardiac or non-cardiac disease can likely account for the symptoms or abnormalities present. If another cardiac disease co-exists, it is not sufficient to cause the degree of myocardial dysfunction present (e.g. ischemic or valvular heart disease or long-standing hypertension). No other etiology of DCM can be determined, such as blood or cocaine use, hypertension, morbid obesity, or other causes. A follow up report received 10/23/2003 adds: To best of reporter's knowledge, the Anthrax vaccine dose #3 was administered overseas sometime in 7/03. The exact date is unknown. No additional vaccines were administered at that time. 60-day follow up on 03/24/04: "Pt has recovered from adverse events. I spoke to pt via telephone on 03/02/04 and he reported that he had a heart transplant accomplished on 10/11/03.  He reports "feeling fine", no shortness of breath or chest pains.  He was last seen at the hospital 02/16/04 where he had an ECHO and a MUGA scan that were both "good" according to the pt and he has a return appointment scheduled for May.  He had a medical board which awarded him 100% compensation and is currently on the following medications: Cyclosporine 150mg two times a day, Mycophenolate 1000mg two times a day, Prednisone 10mg daily, Prilosec 20mg daily, Lisinopril 5mg daily, Magnesium oxide 420mg two times a day, Lescol 80mg daily, throch myec 10mg daily, KCL 20mEq daily and Bactrim DS every Mon, Wed, Fri.  He says that he exercises by walking at his own pace daily and has gained 15lbs.  Current weight: 160."
Rash and swelling under the right arm and down the right side of  body under the right breast,   treatment was Tylenol,  lasted about 7 days
This spontaneous report was received from a female non-pregnant patient (physician) via a company representative, who was reporting on herself. The physician is a female on unknown age. Her concurrent condition included sinusitis. The patient's medical history and drug reactions or allergies were not reported. On unknown date, reported as "in the fall 1999", the patient was vaccinated with a dose of PNEUMOVAX 23 for prophylaxis (dosage, route of administration, lot# and expiration date were not reported). Concomitant therapies included cefuroxime axetil (CEFTIN). In approximately fall, reported as "within 24 hours of the administration", the patient developed swelling of her arm where the PNEUMOVAX 23 was administered and fever of 104 degrees (degree not specified). In approximately 1999, the patient sought for medical attention and was taken to the hospital, where the diagnosis was determined to be acellular cellulitis and allergic reaction to PNEUMOVAX 23. The therapy for sinusitis with with cefuroxime axetil (CEFTIN) was continued. Ibuprofen and TORADOL were given for the fever. In approximately 1999, reported as after 4 days, the patient was discharged from the hospital. The outcome of injection site swelling, allergic reaction to PNEUMOVAX 23 and acellular cellulitis was reported as recovered/resolved (exact date was not specified). The causality assessment between the injection site swelling, acellular cellulitis and therapy with PNEUMOVAX 23 was not reported. The causality assessment between the allergic reaction  and therapy with PNEUMOVAX 23 as related. Upon internal review, the event of acellular cellulitis was considered to be medically significant.
16 hours after receiving the shot, I woke up with a very rapid heartrate (120).  It did slow down somewhat (to the 90s) after a while.   However, sporadically over the next few days, I did feel it was elevated.   Later that day, one day after getting the shot, I developed a severe migraine headache--which included nausea and two bouts of vomiting (1 in the late afternoon and one in the evening of March 12th).  The headache resolved sometime on Sunday, March 14th although I felt a bit weak and shaky.   Currently, five days after receiving the shot, I feel a bit "shaky", and feel that my heartrate is rapid on occasion.
Pt developed lightheadedness after receiving vaccine. VSS. BP 138/71, HR 89, O2sat 100 RA. Denies sob, ha, dizziness, cp. Reports anxiety. Discharged in stable condition.
I experienced numbness and tingling in left arm post injection about 10 minutes after.  About 20 minutes post injection I began to develop tightness in chest, hoarseness in voice, dizziness and weakness.  I then took myself into emergency department.  Arrived at ER at about 11:15am. At this point the tightness in my chest and voice hoarseness had worsened and I had developed a severe headache and neck pain.  I was triaged and immediately taken to a room for IV administration of fluids, Benadryl, Solumedrol, Pepcid.  An EKG was performed and I was found sinus tachycardic.  I was also provided Zofran for my nausea symptoms.  After being monitored for a few hours and my symptoms had improved I was discharged home.  Remaining symptoms were severe headache, neck pain and body weakness.  I was discharged at about 3pm on 11/20/2012.  I returned to ER at about 7:45pm due to return of tightness in chest, hoarseness in voice, increased body weakness and severe head and neck pain as well as neck and upper body stiffness.  An EKG and chest xray were performed as well as a spinal tap.  I was provided IV fluids, Morphine, Zantac, lorazepam, hydromorphone, diazepam and ketorlac.  I was monitored and when symptoms lessened I was discharged home with medications and instructions to return if symptoms worsened.  I was given prescription for Vicodin, Benadryl, prednisone, Zantac.  I was discharged at about 2:00am on 11/21/2012 with medication allergic reaction and possible viral syndrome due to increased WBC.  I returned again to ER on 11/23/2012 at around 10:00am due to increased head and neck pain, body weakness, nausea, fatigue and neck and upper body stiffness.  I was again provided IV fluids, morphine, Valium and Zofran for nausea symptoms.  I was monitored and discharged home with diagnosis of post medication allergic reaction, and spinal headaches. I was provided prescription for Fioricet and Valium and instructed to follow up with primary doctor and return if worsened symptoms.  Follow up with my primary was performed on 11/28/2012.  I am still experiencing the severe head pain, minor neck pain and over fatigue and malaise.
15 Min post pediatric Pfizer vaccination, patient had a hive reaction on her face and hands and reported her ?throat was itchy?. RN administered 25mg IM Benadryl. 911 was called while VS were taken. BP 104/80 HR 83 Regular, SpO2 100%, RR 16. No breathing difficulties noted. Patient was observed and stated she stated felt a lot better .  EMS arrived. Report and care of patient transferred to EMS.  EMS recommended patient should go to the ER, however Mother refused and stated she would prefer to take her daughter to doctor.
Patient said same day developed redness, large welt (several inches) which she described as a hive, swelling which continued several weeks later. She states it is still very painful until today (28 days later). She has a future doctor's appointment for Tuesday
loss of muscle tone of my cheek and inability to smile on the left side; Loss of sensation of my left cheek from under my eye to my mouth; loss of muscle tone of my cheek and inability to smile on the left side; This is a spontaneous report received from a contactable consumer (patient). A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176, expiry date: unknown), via an unspecified route of administration in the left arm, on 29Jan2021 07:30, at single dose, for COVID-19 immunization, at the hospital. Medical history included hypertension, diabetes, increased cholesterol and COVID-19 prior to vaccination. The patent has no allergies to medications, food, or other products. Concomitant medication included enalapril, hydrochlorothiazide, atorvastatin (LIPITOR), and metformin. The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2. The patient was not tested for COVID-19 since the vaccination. The patient experienced "loss of sensation of my left cheek from under my eye to my mouth.  My wife noted loss of muscle tone of my cheek and inability to smile on the left side" on 29Jan2021 at 08:30. Symptoms started about one hour after the injection and resolved after 3 hours. No treatment was received for the events. The outcome of the events was resolved on 29Jan2021 at 11:30. The reporter assessed the events as non-serious.